MTDR (MTDR)

$8.2B
Market Cap
10.8
P/E Ratio
1.05
Beta
2.29%
Dividend Yield
Piotroski 5/9Altman Z 1.9 Gray ZoneBeneish M -3.25 CleanROIC−WACC +0.0%

Quantitative Summary

Deterministic

Financial health is average: Piotroski 5/9, Altman Z 1.9.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The company demonstrates a robust quality profile anchored by an ROIC of 9.2%, indicating capital efficiency that likely exceeds the cost of equity for many peers, while maintaining strong profitability metrics with a net margin of 20.8% and gross margin expanding to 45.8%. The DuPont decomposition reveals that earnings power is primarily driven by high operating leverage rather than asset turnover or financial leverage; specifically, the 12.7% ROE stems from superior margins (20.8%) amplified moderately by a 1.95x equity multiplier and modest asset turnover of 0.31x. Fundamental integrity appears solid given a Piotroski F-Score of 5/9 and a Beneish M-Score of -3.25, the latter suggesting low probability of financial manipulation despite revenue growth moderating at just 5.1% year-over-year.

Valuation metrics present a compelling divergence between historical norms and current pricing, with a forward P/E of 10.8x trading significantly below typical expansion multiples for firms exhibiting such margin profiles. While the DCF model implies fair value based on these margins, the market appears to be pricing in slower growth trajectories or sector-specific headwinds that are not fully reflected in the low multiple relative to its earnings yield. This discount creates a potential mean-reversion opportunity if revenue acceleration resumes, though the current 5.1% growth rate suggests the stock is being valued as a value play rather than a high-growth equity despite its efficient capital structure.

Insider activity provides a nuanced counterpoint to the valuation narrative; over the last ninety days, insiders have executed $38,326 in net buying, signaling moderate confidence from management or key stakeholders at these price levels. However, this flow is relatively small compared to typical institutional accumulation patterns for undervalued names, suggesting that while internal parties see merit, there may be limited aggressive conviction driving a broader re-rating absent significant catalysts like accelerated revenue expansion or margin improvement beyond current baselines.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

5/9
Piotroski F-Score
Average — mixed operational signals
1.9
Altman Z-Score
Grey Zone — between 1.8 and 3.0 thresholds. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-3.25
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

45.8%
Gross Margin
20.8%
Net Margin
9.2%
ROIC
9.2%
WACC
ROIC − WACC Spread: +0.0%— Positive spread.
+5.1%
Revenue Growth (YoY)
-14.2%
Earnings Growth (YoY)
241.6M
Free Cash Flow
67%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

20.8%
Net Profit Margin
NI ÷ Revenue
×
0.31x
Asset Turnover
Revenue ÷ Assets
×
1.95x
Equity Multiplier
Assets ÷ Equity
=
12.7%
Return on Equity
✅ ROE driven primarily by strong profit margins — a sign of pricing power.

Balance Sheet Health

0.95x
Debt / Equity
0.79x
Current Ratio
6.0x
Interest Coverage
1.4x
Net Debt / EBITDA
2.08%
FCF Yield
2.4B
EBITDA

Insider Activity (Last 90 Days)

Net Insider Flow
+$38,326
Net Buying
2
Buy Transactions
0
Sale Transactions
2026-03-06EHRMAN MONIKA U.Buy$15,029
2026-02-27FORAN JOSEPH WMBuy$23,297
2026-02-13ELSENER WILLIAM THOMASGrant$239,000
2026-02-13ERMAN BRYAN A.Grant$286,800
2026-02-13CALVERT CHRISTOPHER P.Grant$286,800

Open-market buys vs sells by company insiders. Source: yfinance.

Earnings Surprise History

Q4
✓ Beat
Est: $1.78
Act: $1.99
+11.6%
Q3
✓ Beat
Est: $1.41
Act: $1.53
+8.2%
Q2
✓ Beat
Est: $1.23
Act: $1.36
+11.0%
Q1
✓ Beat
Est: $0.76
Act: $0.87
+15.1%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

9.5
Forward P/E
PEG Ratio
1.45
Price/Book
2M
Avg Volume
$66.84
52W High
$35.19
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$578M
Tracked Passive Exposure
8
ETFs Holding MTDR
0.12%
Avg Weight in ETFs
$478B
Total ETF AUM

When investors buy or sell ETFs like XOP or MDYV, the fund manager is mechanically forced to buy or sell MTDR shares regardless of MTDR's individual fundamentals. We estimate $578M of passive capital is structurally linked to MTDR through 8 tracked ETFs. Passive flows have a limited but growing influence on MTDR's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in MTDR to visualize passive redemption contagion across ETFs and collateral stocks.

MTDR Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
MTDREpicenterVBETFVYMETFVXFETFXOMLow RiskCVXLow RiskCOPLow RiskEOGLow RiskDVNMed Risk
MTDR Price Drop (%)0

If MTDR (MTDR) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Exxon Mobil Corp. (XOM) as the most exposed collateral stock, sharing 1 ETFs with MTDR. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 13 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

MTDR Ownership Dynamics

Ticker
MTDR

Float lock-up computed from 13 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

MTDR Capital Efficiency

How efficiently does MTDR convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$242M
EBITDA
$2.4B
FCF Conversion
10%
Reinvestment Rate
90%
10% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
9.2%
ROIC − WACC Spread
0.0%

MTDR converts 10% of its EBITDA into free cash flow, a low conversion rate suggesting heavy reinvestment. This may indicate a growth phase (building capacity) or structural capital intensity. The 90% reinvestment rate signals aggressive capacity expansion. The positive ROIC-WACC spread of 0.0% confirms that reinvested capital creates shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-076,524$57.76$376,826.24
2026-05-0612,726$62.93$800,847.18
2026-05-05191$63.82$12,189.62
2026-05-043,503$62.36$218,447.08
2026-04-2026$55.60$1,445.6
2026-04-14147$60.31$8,865.57
2026-04-095,306$60.34$320,164.04
2026-04-081,211$64.49$78,097.39
2026-03-271$64.20$64.2
2026-03-23391$58.50$22,873.5
2026-03-1712,268$56.36$691,424.48
2026-03-1315,878$56.16$891,708.48
2026-03-1192$54.48$5,012.16
2026-03-1014,014$56.15$786,886.1
2026-03-02197$51.40$10,125.8
2026-02-2747,626$49.62$2.4M
2026-02-1747$47.80$2,246.6
2026-02-1354,496$46.84$2.6M
2026-01-231,584$43.15$68,349.6
2026-01-0245$42.44$1,909.8
2025-12-2645$41.73$1,877.85
2025-12-1914,375$40.91$588,081.25
2025-12-125,038$44.89$226,155.82
2025-12-09345$44.42$15,324.9
2025-12-042,550$44.28$112,914
2025-11-26875$41.23$36,076.25
2025-11-142,378$40.80$97,022.4
2025-11-1297,835$40.54$4.0M
2025-11-066,042$37.19$224,701.98
2025-10-3094$39.70$3,731.8

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare MTDR to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.